More News

01 Mar 2007 XOMA and Takeda Expand Collaboration for Therapeutic Antibody Discovery and Development
01 Mar 2007 Organon and Acrux to develop contraceptive sprays
28 Feb 2007 Initiation of Phase III Program Using Emisphere's eligen(R) Technology for Oral Salmon Calcitonin
28 Feb 2007 Nautilus Biotech announces IND filing for Belerofon, its oral, long-lasting, Interferon-alpha drug
28 Feb 2007 Vaccinex Announces Antibody Development And Commercialization Alliance In Multiple Sclerosis And Oncology
28 Feb 2007 EvoGenix and Vegenics announce collaboration
28 Feb 2007 PPD Licenses Statin from Ranbaxy Laboratories
27 Feb 2007 Bristol-Myers Squibb Company and Adnexus Therapeutics Announce Collaboration to Develop and Commercialize Innovative Oncology Compounds
27 Feb 2007 Ipsen Grants Galderma Exclusive Rights to Develop, Promote and Distribute Its Botulinum Toxin Type A Product for Aesthetic Indications in Europe and Certain Other Territories
27 Feb 2007 Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP
27 Feb 2007 Taro Receives Tentative Approval for Ranitidine Syrup ANDA
27 Feb 2007 Azur Pharma Announces the Acquisition of Pharmelle
27 Feb 2007 BD Biosciences and Roche Collaborate to Advance the Study of Cell Signal Transduction through New Phosphorylation Site Antibody Targets and Applications
27 Feb 2007 VGX Pharmaceuticals and ADViSYS Announce Merger Agreement: Creation of VGX Immune Therapeutics Division
27 Feb 2007 Graffinity and Amgen Enter into Drug Discovery Research Agreement
27 Feb 2007 Novelix Announces Licensing of Cancer Compound to AOP Orphan Pharmaceuticals
27 Feb 2007 Trius Therapeutics Completes $20 Million Series A Financing and Names CEO
24 Feb 2007 Focetria(R) pandemic influenza vaccine receives positive European Union regulatory agency opinion supporting approval
23 Feb 2007 TorreyPines Therapeutics and Eisai Co., Ltd. Extend Alzheimer's Disease Collaboration Agreement
23 Feb 2007 Teva Announces Approval of Rabeprazole Sodium Delayed-Release Tablets
23 Feb 2007 Ikaria Inc. And Investor Group To Acquire INO Therapeutics In $670 Million Cash And Stock Merger, Creating A World Leader In Critical Care Therapeutics
23 Feb 2007 Bedford Laboratories receives FDA approval for Methylprednisolone Sodium Succinate for Injection, USP
22 Feb 2007 TransTech Pharma, Inc. obtains exclusive licence to glucokinase activator programme for the treatment of diabetes from Novo Nordisk
22 Feb 2007 Breakthrough oral delivery for arthritis sufferers
22 Feb 2007 BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteonecrosis of the Jaw

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up